Success Metrics

Clinical Success Rate
100.0%

Based on 18 completed trials

Completion Rate
100%(18/18)
Active Trials
0(0%)
Results Posted
6%(1 trials)

Phase Distribution

Ph phase_4
1
6%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

18 of 18 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(18)

Detailed Status

Completed18

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

completed18100%

Recent Activity

0 active trials
Showing 5 of 18
completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

NCT01263457
completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

NCT02015273
completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

NCT01555528
completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia

NCT02208076
completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece

NCT01363674
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT01263457

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

Completed
NCT02015273

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

Completed
NCT01555528

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

Completed
NCT02208076

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia

Completed
NCT01363674

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece

Completed
NCT01438528

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

Completed
NCT01267526

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment

Completed
NCT01307059

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden

Completed
NCT01400997

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

Completed
NCT01582334

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

Completed
NCT01402999

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary

Completed
NCT01291394

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

Completed
NCT01296425

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria

Completed
NCT01376921

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain

Completed
NCT01400984

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

Completed
NCT02015286

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

Completed
NCT01309555

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia

Completed
NCT00689260Phase 4

Easypod United States User Trial

Completed

All 18 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
18